The major identifiable causes of death of the insulin cohort included: 10 (0.97%) CV death (1 ischemic heart disease, 3 sudden cardiac deaths, 1 heart failure, 2 stroke, 3 CV hemorrhage); 142 (13.832%) noncardiovascular death (52 cancers, 90 others); and 14 (1.36%) undetermined cases. Here, INS is linked to cancer.